United States

Catalyst Pharmaceuticals Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

30 Sep 2016
Change (% chg)

$-0.03 (-2.68%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Catalyst Pharmaceuticals Partners Inc proposes settlement of pending securities class action lawsuit
Tuesday, 4 Nov 2014 08:03am EST 

Catalyst Pharmaceuticals Partners Inc:Says that it has entered into a memorandum of understanding to settle its pending class action securities lawsuit.As previously disclosed, the company and one of its executive officers are defendants in a class action lawsuit filed in the U.S. District Court for the Southern District of Florida.Amended complaint purports to state a claim for alleged misrepresentations regarding the development of Firdapse(tm) on behalf of a class of those who purchased shares of the company's common stock between Aug. 27, 2013 and Oct. 18, 2013.  Full Article

BRIEF-Catalyst Pharmaceuticals' board entered into amendment no. 1 to rights agreement

* On September 19, 2016, board unanimously approved, and entered into amendment no. 1 to rights agreement - SEC filing